MedTrace Logo

Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome

NCT02579902 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2015-11-30

No results posted yet for this study

Summary

The purpose of this study is to determine whether vitamin D3 supplementation is effective in the treatment of clinical signs, biomarkers of inflammation and oxidative stress due to Irritable Bowel Syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 (Cholecalciferol)

50000 IU Vitamin D3 (Cholecalciferol) will be given as one gelcaps every 2 weeks for a period of 6 months.

DIETARY_SUPPLEMENT

placebo

placebo will be given in identical gelcaps once every 2 weeks for a period of 6 months.

Sponsors & Collaborators

  • Ahvaz Jundishapur University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02579902 on ClinicalTrials.gov